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Abstract
Background: Recent research supports that aggregation of islet amyloid polypeptide (IAPP) leads to cell death and this
makes islet amyloid a plausible cause for the reduction of beta cell mass, demonstrated in patients with type 2 diabetes.
IAPP is produced by the beta cells as a prohormone, and proIAPP is processed into IAPP by the prohormone convertases
PC1/3 and PC2 in the secretory granules. Little is known about the pathogenesis for islet amyloid and which intracellular
mechanisms are involved in amyloidogenesis and induction of cell death.
Methodology/Principal Findings: We have established expression of human proIAPP (hproIAPP), human IAPP (hIAPP) and
the non-amyloidogenic mouse IAPP (mIAPP) in Drosophila melanogaster, and compared survival of flies with the expression
driven to different cell populations. Only flies expressing hproIAPP in neurons driven by the Gal4 driver elav
C155,Gal4 showed
a reduction in lifespan whereas neither expression of hIAPP or mIAPP influenced survival. Both hIAPP and hproIAPP
expression caused formation of aggregates in CNS and fat body region, and these aggregates were both stained by the
dyes Congo red and pFTAA, both known to detect amyloid. Also, the morphology of the highly organized protein granules
that developed in the fat body of the head in hIAPP and hproIAPP expressing flies was characterized, and determined to
consist of 15.8 nm thick pentagonal rod-like structures.
Conclusions/Significance: These findings point to a potential for Drosophila melanogaster to serve as a model system for
studies of hproIAPP and hIAPP expression with subsequent aggregation and developed pathology.
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Introduction
Today, there are 27 proteins that have been identified as main
component of amyloid deposits in human [1]. Of these proteins, 14
form amyloid fibrils with a deposition restricted to a single tissue or
organ, and these diseases are referred to as localized amyloidosis.
There is no biochemical relationship between these amyloid
proteins, but interestingly, five of those are polypeptide hormones,
recognized to be stored in the secretory granules at high
concentration, a known risk factor for aggregation. Some of the
local forms of amyloid diseases are connected to severe maladies,
suchastype2 diabeteswhereIAPPmisfolds and deposits asamyloid
in the islet of Langerhans [2,3], and Alzheimer’s disease where the
Ab protein is deposited in the CNS [4].
In recent years, the role for hIAPP in the development of type 2
diabetes has gained a lot of attention. In particular, the formation
of cell toxic oligomers as a cause for the observed reduction of
insulin producing cells, detected in these patients are believed to be
important [5]. IAPP is produced by the beta cells [6] and co-
secreted with insulin upon stimulation [7]. IAPP acts as a
modulator for insulin release and reduces voltage-gated calcium
channel activation and insulin secretion [8]. IAPP is synthesized as
a 67 residues prohormone, and undergoes posttranslational
processing to become biologically active. This is performed by
the prohormone convertases PC1/3 and PC2 and takes place in
the secretory granules [9]. Deficiency in processing of hproIAPP
into hIAPP is associated with an increase in amyloidogeneity [10].
Expression of human preproIAPP in cell lines deficient of PC2
(GH3, American type culture collection, Manassas, VA) and/or
PC1/3 (GH4C1, AtT-20, American type culture collection)
increases the risk for amyloid formation [11] and cell death by
apoptosis [12]. It was also shown that hproIAPP and hIAPP both
spontaneously form amyloid like fibrils in vitro [13,14]. Little is
known about the mechanisms that cause a native protein to unfold
and misfold into amyloid [15]. Islet amyloid is present to some
degree in almost all individuals with type 2 diabetes [16,17]. The
amyloid load correlates to some degree with the severity of the
diabetes condition in that patients that demand insulin for
treatment of their disease have more amyloid deposited [18]. In
Asian populations a single point mutation in the IAPP gene
(IAPPS20G) [19] has been linked to an increased risk to develop
type 2 diabetes [20]. Islet amyloid develops also in old cats [21]
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islet amyloid correlates with fasting plasma glucose levels [24].
Mouse and rat do not develop islet amyloid; this is a difference that
depends on the amino acid sequence and especially three proline
residues present in the region 20–29 of rodent IAPP are thought to
be responsible for this [25]. Therefore, different transgenic strains
that express human IAPP have been created. Studies performed
with these animals support the importance of islet amyloid for
development of diabetes [26,27].
The present work aims to establish a new in vivo model for
expression of IAPP or proIAPP that could be used for elucidation
of intracellular events triggered by protein aggregation. We used
Drosophila melanogaster as model system which is already established
for several other amyloid related diseases, such as Alzheimer’s
disease [28], familial amyloidotic polyneuropathy (FAP) [29,30],
and the prion disease Gerstmann-Stra ¨ussler-Scheinker syndrome
[31].
Herein, we describe that hproIAPP expression reduces longevity
of Drosophila when expressed in the CNS, while longevity is not
influenced by hIAPP or mIAPP expression. Furthermore, we were
able to demonstrate that both hproIAPP and hIAPP are
successfully secreted from the neurons, and assemble into
aggregates with amyloid tinctorial characteristics. After secretion
the peptides can be taken up by cells in the fat body of the head. In
these cells the proteins form highly ordered protein aggregates
with a rod-like structure.
Results and Discussion
Transgenic Drosophila melanogaster
In human, IAPP together with calcitonin [32], calcitonin gene
related peptide (CGRP) [33], adrenomedullin [34], and interme-
din/adrenomedullin 2 [35] are all members of the calcitonin gene
family that are important for regulation of a diversity of
physiological functions. The Drosophila melanogaster genome was
searched for nucleotide or amino acid sequences similar to any of
these five polypeptide hormones, but without any success.
A large number of transgenic strains expressing hproIAPP,
hIAPP or mIAPP were successfully established, and the expected
DNA sequences of the different transgenes were verified after
sequencing. The amino acid sequence for hIAPP and mIAPP are
presented in Figure 1 A, and the posttranslational processing sites
for hproIAPP are presented in Figure 1 B. The survival of the
three hproIAPP lines hproIAPP#14.2, hproIAPP#18.5 and
hproIAPP#20.4 were compared to the survival of hemizygous
Gal4 expressing control flies, and all three hproIAPP transgenic
flies showed reduced survival when compared to the hemizygous
Gal4 control flies. HproIAPP#14.2 and hproIAPP#18.5 had
significantly reduced survival with p-values of ,0.0001 and
0.0175, while flies from line 20.4 did not reach a significant
reduction (p-value=0.0577) (Figure S1). The relative amounts of
hproIAPP mRNA was determined by QT-PCR. When the values
were normalized against the mRNA levels for hproIAPP#14.2,
the levels for hproIAPP#18.5 and hproIAPP#20.4 lines were
determined to be 249% and 128%, respectively. A double
transgenic hproIAPP expressing fly were established by crossing
hproIAPP#20.4 and hproIAPP#14.2 flies. Survival analysis of
this double hproIAPP fly line showed a reduced survival
(p,0.0001) compared to hemizygous Gal4 expressing control
flies. Survival analysis were also carried out on four hIAPP lines
and four mIAPP lines, and neither of these lines revealed any
reduction in survival when compared to hemizygous Gal4
expressing control flies. The mRNA expression levels for the
hIAPP lines were normalized against hIAPP#6 and determined
to be 42% in hIAPP#1, 89% in hIAPP#2 and 110% in hIAPP#5
flies. The mRNA expression levels for mIAPP were normalized
against the mIAPP#9 and determined to be 435% in mIAPP#1,
110% in mIAPP#2 and 170% in mIAPP#3 flies.
Since the mRNA expression levels of hIAPP and mIAPP did not
affect the survival the transgenic lines hIAPP#6, mIAPP#9 and
hproIAPP#14.2 were selected for the further work. All lines had
red eyes with the same intensity.
The expression levels for the hproIAPP#14.2, hIAPP#6 and
mIAPP#9 transgenes were analyzed by QT-PCR, and levels for
hIAPP and mIAPP were determined to be 72% and 62% of
hproIAPP, respectively.
Generation of transgene expressing flies and control flies
Transgenic flies were generated by crossing male flies from an
UAS-stock with female virgin flies from the respective Gal4 driver
line. The female offspring used for the study was therefore,
hemizygous for the Gal4 driver (Figure 2 A). For generation of
control flies, male w
1118 flies were crossed with female virgin flies
of the respective Gal4 driver. W
1118 flies are used for control
crosses since the P-element insertion of the UAS-transgenes was
done in w
1118 flies (Figure 2 B).
Survival assay
In order to select an optimal expression system we compared
the survival of flies expressing hproIAPP in different cell
populations. Five commercially available Gal4 driver lines were
used: the pan-neuronal Gal4 driver P(GawB)elav
C155 [36], the
motor neuron Gal4 driver P(GawB)D4 [37], the mushroom body
Gal4 driver P(GawB)7B [38], the glia cell Gal4 driver P(Gal4)repo
[39], and the photoreceptor Gal4 driver line P(Gal4-ninaE.GMR)
[40]. Male flies from the UAS-hproIAPP transgenic line were
crossed with female virgin flies of the respective Gal4 driver and
the survival of the female progeny expressing hproIAPP was
monitored, and compared with the longevity of the control flies
(female progeny derived from crosses of male w
1118 flies with
female virgin flies hemizygous for the respective Gal4 driver (Gal4/
+)). These survival assays were performed, at 26uC. HproIAPP
expression driven by the pan-neuronal Gal 4 driver elav
C155 lead
to a reduced longevity when compared with the appropriate Gal4
control (elav
C155, Gal4/+) (n=100, p,0.001) (Figure 1 C, green
and black, respectively). The survival of hemizygous UAS-hproIAPP
flies (UAS-hproIAPP transgenic flies backcrossed with w
1118 flies,
UAS-hproIAPP/+) was also monitored. These flies had a significant
increased lifespan compared to flies expressing hproIAPP driven
by elav
C155 (n=100, p,0.001), (Figure 1 C, grey), but they lived
also longer than elav
C155,Gal4/+ control flies.
It is known that the metabolism in Drosophila is influenced by
temperature. To evaluate how temperature affects the longevity of
hproIAPP expressing flies, male UAS-hproIAPP flies were mated
with female virgin elav
C155,Gal4 flies at 26uC and the survival of
hatched female flies was monitored, at 18uC and 29uC. The
significant reduction in lifespan persisted also for flies expressing
hproIAPP at 18uC and 29uC compared to Gal4/+ control flies (in
both cases: n=100, p,0.001 (Figures S2 B and C).
When expression of hproIAPP was induced by any other of the
Gal4 drivers, the flies transgenic for proIAPP had a prolonged
survival in comparison to their respective Gal4/+ control flies
(Figures S3 A–D, right panel). To confirm the expression patterns
for the different Gal4 driver lines, flies from each line were mated
with flies from a UAS-nlsGFP line. Whole-mount brains from
progeny flies were stained for GFP and the reaction was visualized
by a secondary antibody labelled with Alexa 488. At the same time
the brains were counter-stained with an antibody reactive against
Islet Amyloid Polypeptide in Drosophila
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20221Figure 1. One letter code for human and mouse IAPP residues 1–37. Amino acid identity is shown in green and residue substitutions are
shown in black, except for the three proline residues substitutions present in mouse IAPP that are shown in red (A). Proline residues are known beta-
breakers and it is believed that these residues hinder IAPP-aggregation. ProIAPP processing. In man, proIAPP is synthesised as a 67 residue long
polypeptide that undergoes posttranslational cleavage at dibasic residues (red) performed by the prohormone convertases PC2 and PC1/3. The two
basic residues that remain at the C-terminus after PC1/3 processing are removed by carboxypeptidase E. Thereafter, the remaining C-terminal glycine
residue is used for C-terminal amidation. A disulphide-bond is formed between residues 2 and 7 (B). Survival curve for flies expressing hproIAPP
shows a reduction in life span. Expression of proIAPP was directed to neurons by the elav
C155,Gal4 driver (C). This expression resulted in a significant
reduction of lifespan (green), when compared to control flies (elav
C155,Gal4, black) or flies containing UAS-proIAPP only (grey). These latter flies contain
the inserted DNA, but do not express the corresponding protein due to absence of Gal4. (D) Comparison of the survival of hIAPP (brown) and
elav
C155,Gal4, (black) expressing flies shows that hIAPP expression does not reduce the survival (p.0.05). The hproIAPP (green) expressing flies
showed a significant shorter lifespan than hIAPP (brown, p,0.001). (E) Comparison of the survival of mIAPP (blue) with control flies elav
C155, Gal4,
(black) showed that mIAPP expression does not reduce the survival of the flies (p.0.05). Flies expressing mIAPP (blue) lived longer than hproIAPP
Islet Amyloid Polypeptide in Drosophila
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secondary antibody labelled with Alexa 546. The result thereof
verified that all Gal4 lines had the expected expression pattern
(Figures S2 A and S3 A–D, left panel).
From the result of the survival assay it can be concluded that the
observed decrease in survival of elav
C155,Gal4.proIAPP flies relates
to the expression of hproIAPP and it is not just a consequence due to
changes in the genetic background, caused by insertion of the UAS-
hproIAPP into the fly genome (Figure 1 C, green and grey). The
unaltered or increased survival of flies detected after hproIAPP
expression driven by the Gal4 driver to motor neurons, mushroom
body, glia cells or photoreceptors is not easily explained (Figure S3
E). Surprising was the finding that when hproIAPP expression was
driven to the photoreceptors by GMR-Gal4 the median survival was
markedly increased compared tothe GMR-Gal4controls. When the
amyloid protein transthyretin (TTR) was expressed in the
photoreceptors this reduced the survival of the files [30]. In addition,
TTR expression lead to a distortion of the eye morphology [30], a
finding also reported by Berg et al. [29] and by Crowther et al. after
Ab expression driven to the same cellular location [41]. We have
looked for morphological changes of the eye structure after
hproIAPP expression, but neither TEM analysis of ommatidia nor
SEM analysis of external eye structure showed any morphological
deviations. As verified by the GMR driven nlsGFP expression
(Figure S3 D, left panel), cells localized to the photoreceptor region
synthesize the protein. The variation of median survival days
observed in controls (49, 47, 56, 51, and 34, in Figure S3 E) could
depend on a variation in genetic background including the degree of
Gal4 expression that most likely exists between Gal4 driver lines.
Gal4 itself is known to exert neurotoxic effects and it has been
reported that expression of high amounts of Gal4 in the eye is
associated with apoptotic neuronal loss in Gal4 expressing neurons
Figure 2. Generation of transgene expressing flies. Males from an UAS-transgene stock were mated with female virgins from the Gal4 line of
interest. Female progeny hemizygous for the transgene and Gal4 were selected and used (A). Generation of control flies. Males from w
1118 were
mated with female virgins from the Gal4 line of interest. Female progeny hemizygous for the Gal4 were selected and used. W
1118 flies are used for
control crosses since the P-element insertion of the UAS-transgenes was done in w
1118 flies (B).
doi:10.1371/journal.pone.0020221.g002
expressing flies (green, p,0.001). (F) The median survival for control flies (black), hproIAPP (green), hIAPP (brown) and mIAPP (blue) are 49, 37, 48 and
42 days, respectively, and the survival of hproIAPP flies is significantly reduced when compared to flies from the control, hIAPP and mIAPP strains
(p,0.001).The survival for hIAPP flies is not reduced when compared to mIAPP or control flies. The survival studies were performed in an incubator
with 70% humidity, at 26uC.
doi:10.1371/journal.pone.0020221.g001
Islet Amyloid Polypeptide in Drosophila
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reduced longevity observed in response to TTR and Ab GMR
driven expression could depend on a general amyloid mechanism.
That is that amyloid fibril formation is a self-driven process, and if
initiated the process will continue as long as the precursor is present.
This pathway includes also the formation of small cell toxic protein
species, known as oligomers. The absence of detectable pathology
after hproIAPP expression with 4 out of 5 Gal4drivers could depend
on that aggregation was not initiated. This in turn could depend on
low protein expression levels or a rapid clearance of hproIAPP.
To elucidate if the toxic phenotype was restricted to hproIAPP
we crossed UAS-hIAPP and UAS-mIAPP with elav
C155,Gal4, and
survival was monitored at 26uC. It was shown that the survival of
flies expressing hIAPP and mIAPP did not differ from that of
elav
C155,Gal4 control flies (p.0.05), and both lived longer than flies
expressing hproIAPP p,0.001 (Figures 1 D and E). Median
survival days of flies expressing mIAPP (42 days), hIAPP (48 days)
or elav
C155,Gal4/+controls (49 days), did not show any significant
difference (for each comparison: n=100, p.0.05) (Figure 1 F).
The absence of reduced survival in flies expressing hIAPP and
mIAPP when compared to hproIAPP expressing flies is not related
to the level of transgene expression since no significant variation
between the four hIAPP lines or between the four mIAPP lines was
observed (p.0.05 for hIAPP and p.0.05 for mIAPP).
Immunological detection of expressed protein
Based on the results from the lifespan assay we selected the
elavC155,Gal4 driver for our model system. The median age for
elav
C155,Gal4.hproIAPP and elav
C155,Gal4.hIAPP flies were 37 and
48 days respectively (Figure 1 F), and we know from human that the
incidence of amyloid increases with age. Therefore, transgenic flies
were aged for 40 days, at 26uC. Immunofluorescence analysis was
performed on brain sections of elav
C155,Gal4.hproIAPP and
elav
C155,Gal4.hIAPP flies. The investigated area is indicated in
Figure 3 A and areas of interest are highlighted in the cartoon in
Figure 3 B. Immunolabeling was performed with a rabbit polyclonal
antibody raised against human IAPP, and simultaneous detection of
Gal4 positive neurons was performed with an anti-elav specific
antibody. IAPP reactivity was detected in some neuronal cells, at site
of expected expression as judged by anatomic localization (Figures 3
C and D). In addition to neurons, IAPPreactivity was also detected in
the fat body in elav
C155,Gal4.proIAPP and elav
C155,Gal4.IAPP flies
(Figures3 Fand G).No IAPPlabellingoccurredatanysiteinsections
from elav
C155,Gal4/+ control flies (Figure 3 E and H). The head fat
body tissue is present outside the humoral-brain-barrier, and no
expression of the transgene was expected to take place at this location.
This shows that the signal peptide containing transgenic protein was
secreted fromthe neuronsandaccumulated inthe fatbodytissue.We
would liketopointout thatthepositive staining ofthe cellsinthehead
fat body in our hproIAPP and hIAPP expressing flies was widespread
and not limited to a certain cell population.
In contrast to the advanced labelling of the head fat body, only a
subset of neurons was found to be immunolabelled for proIAPP
and IAPP. It is possible that visible immunoreactivity occurs at
sites where proIAPP or IAPP is accumulated while the general
absence of reactivity depends on synthesis below the detection
level and rapid secretion. The expression of hproIAPP, hIAPP and
mIAPP was also studied in younger flies, 5 and 15 days old flies,
aged at 26uC. Immunofluorescence analysis was performed on
brain sections from elav
C155,Gal4.hproIAPP, elav
C155,Gal4.
hIAPP and elav
C155,Gal4.mIAPP flies with a mouse monoclonal
antibody reactive against human IAPP. Compared to 40 days old
flies, the number of IAPP reactive neurons was higher in 5 days
old flies expressing hproIAPP (Figure 4 A), hIAPP (Figure 4 B),
and mIAPP and remained increased also in15 days old flies
(Figures 4 E–J). No staining could be detected in elav
C155,Gal4/
+control flies (figure 4 C and D).
The result raised the question if levels of Gal4 expression
change over time. Males from the, UAS-nlsGFP line were mated
with female virgins from the elav
C155,Gal4 line. The expression
pattern was studied in dissected whole-mount brains immunola-
belled with a primary antibody against GFP and Alexa 488-
labelled secondary antibody, at time points 1, 5, 15 and 30 days.
The result of this study showed that the elav driven expression of
nlsGFP varied over time. Only a limited reactivity was detected in
one day old flies. The highest number of reactive cells was present
at day 5, and already at day 15 was the number of reactive cells
reduced. In brains from 30 days old flies the numbers of reactive
cells was almost comparable to that found in 1 day old flies (Figure
S4). With this result in mind is the detected low immunolabeling in
brains of older flies not surprising.
To determine if IAPP reactivity in neurons was present
extracellularly and/or intracellularly the cell nuclei of Gal4
containing cells were labelled with GFP. This was obtained by
the Gal4 dependent expression of UAS-nlsGFP where the
nuclear leading sequence (nls) transfers expressed GFP to the
cell nucleus (Figure 5 A). In a parallel setup these cells also
expressed hproIAPP or hIAPP. After immunolabeling, extra-
cellular IAPP reactivity was detected in both hproIAPP and
hIAPP expressing flies (Figures 5 B and D). This reactivity was
indicative for aggregates, since non-aggregated peptide would
be expected to diffuse. Intracellular IAPP was also present in
both hproIAPP and hIAPP flies (Figures 5 C and D).
Intracellular IAPP reactive material was sometimes extensive
a n dr e p l a c e dt h em a i np o r t i o no ft he cytosol, whilee x t r a c e l l u l a r
aggregates were occational localized to areas free of cell nuclei.
T h i si ss i m i l a rt ot h ep a t t e r ns e e ni nh I A P Pt r a n s g e n i cm i c e
where intracellular aggregatesc o u l dr e p l a c et h ec y t o s o la n d
cause cell death by apoptosis [44].
Processing of hproIAPP in Drosophila Melanogaster
Amontillado is the Drosophila melanogaster homologue to the
mammalian prohormone convertase 2 (PC2). In mammals, PC2
processing of proIAPP results in the removal of the N-terminal
flanking peptide (Figure 1 A). To investigate if hproIAPP was
processed in Drosophila, we performed immunofluorescence analysis
with two different antibodies on head sections from flies with
hproIAPP expression driven by the elav
C155,Gal4 driver. Antibody A-
169 is reactive against the N-terminal processing site of proIAPP
(Figure 6 A), an epitope only present when the N-terminal flanking
peptide is linked to IAPP. This antibody isthereforespecific for the N-
terminal part of proIAPP [11]. Antibody A-142 reacts with the C-
terminal flanking peptide of proIAPP [44] (Figure 6 A), and its
reactivity is independent of IAPP. Antibody A-142 and antibody A-
169 show reactivity on both sides of the humoral-brain-barrier
(Figures 6 B and C). This pattern is comparable to that observed for
IAPP (Figures 3 C, D, F and G). The presence of antibody A-169
reactivity in the cytoplasm of head fat body cells proves that proIAPP
is not cleaved by Amontillado at the N-terminal processing site
(Figures 6 C and D). The reactivity with antibody A-142 in the head
fat body region suggests that the C-terminal flanking peptide
translocates to the same location as the rest of the molecule and
this supports absence of processing.
Deposited hproIAPP and hIAPP was recognized by Congo
red and FTAA
To examine if amyloid was formed in Drosophila we stained
brain sections of aged flies (40 days) with Congo red. As shown in
Islet Amyloid Polypeptide in Drosophila
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C155,Gal4 are secreted from the neurons. (A) The green section highlights the
studied area and the carton in (B) is an overview of the most important histological features present in this region. (C, D, E) Inside the humoral-brain-
barrier, elav positive neurons are shown (green-light blue) and hIAPP (red) is localized to this area (C, D). (F, G, H) cover an area including both sideso f
the blood-brain-barrier where the neurons (green-light blue) are present at the bottom part and the fat body in the top part. In (F, G) are the cells in
the fat body recognized by IAPP antibodies (red). Immunolabeling of IAPP in the fat body cells demonstrates that hproIAPP (F) and hIAPP (G) are
secreted from the neurons, transferred over the humoral-brain-barrier and taken up by cells in the fat body. Cell nuclei are labelled with TOPRO-3 and
visualized as blue. Flies were 40 days old.
doi:10.1371/journal.pone.0020221.g003
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PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e20221Figures 7 B and C, upper panel, material stained with Congo red
was mainly present in the fat body in both hproIAPP and hIAPP
expressing flies, with possible minute staining of aggregates in the
neuronal area. In addition to Congo red, brain sections were
stained for amyloid with pFTAA (lower panel), a recently
described amyloid binding luminescent conjugated oligothiophene
[45,46]. Results obtained from pFTAA staining were similar to
those obtained with Congo red and with both, aggregates made up
by hproIAPP and hIAPP were mainly detected in the fat body
region (Figures 7 B and C, lower panel). Though, pFTAA staining
was more frequent than Congo red. This may depend on the
possible ability of pFTAA to recognize more¨immature ¨ aggregates
in addition to amyloid [47,48]. No amyloid like staining could be
detected in sections from elav
C155,Gal4 control flies or mIAPP
Figure 4. Transgene expression is increased in young flies. The hIAPP, hproIAPP and mIAPP expression driven by the elav
C155, Gal4 driver was
analysed in 5 days (A, B) and 15 days (C–J) old flies. Immunolabeling of whole brain mounts from these younger flies revealed more neuronal
immunoreactivity than detected in 30 and 40 days old flies. The depicted immunoreactivity is within the humoral-brain-barrier, the expected site of
expression. Immunolabeling was performed with a monoclonal antibody that reacts with human and mouse IAPP. Arrows indicates reactivity.
doi:10.1371/journal.pone.0020221.g004
Islet Amyloid Polypeptide in Drosophila
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affinity to the chitin in the exoskeleton, a binding described by
Cohen, in 1993 [49].
To ensure that pFTAA positive material was made up of IAPP-
reactive material, brain sections from flies expressing hproIAPP or
hIAPP were stained with pFTAA and immunolabelled with a
polyclonal antibody against IAPP. In hproIAPP and hIAPP flies,
co-localization of IAPP and pFTAA staining was frequently seen
in the fat body (Figures 8 A and B). Areas only labelled with anti
IAPP-antibodies represent the peptide in a non-amyloid structure.
No area showed pFTAA labelling only (except for the exoskele-
ton). Co-localization of IAPP and pFTAA staining was also seen
inside the humoral-brain-barrier and the reactivity was present
both intracellularly and extracellularly (Figure 8 C).
Ultrastructural analysis of the fat body
The detection of IAPP-immunoreactivity in the fat body of hIAPP
and hproIAPP expressing flies in addition to demonstration of
structures stained with Congo red, and pFTAA prompted us to have
a closer look at the ultrastructure of this tissue. We selected 16 days
old transgenic flies since this is before the drop in survival of proIAPP
expressing flies (Figure 1 C). Control flies on the other hand had yet
another 10 days before their survival started to decline. If alterations
o c c u rw es h o u l db ea b l et od e t e c tt h e ma tt h i ss t a g e ,a n da v o i d
structural changes that might be caused merely by ageing. Frozen
sections were treated with ethanol prior to IAPP and pFTAA staining
since this treatment solubilizes lipids. In these sections pFTAA
(Figure 8 A) and IAPP (Figure 8 B) staining was mainly surrounding
the cell nucleus and with thin rims of labelling present between areas
earlier occupied by lipid drops.
In semi thin sections (1 mm), post-fixed with OsO4 to
preserve lipids, we observed a difference in distribution of
lipid-drops between the different groups of flies. Control and
mIAPP expressing flies had severald i s t i n c td r o p l e t si ne a c hf a t
body cell (Figure S5), while in hproIAPP or hIAPP expressing
flies these cells contained large clusters of lipid drops (Figures 9
A and S5). In sections from the latter flies the thickness of the fat
body region was slightly increased and could contain two layers
of cells and the integrity of the cell borders were lost. In ultra-
thin sections from proIAPP and hIAPP transgenic flies we
detected irregularly shaped aggregates surrounding the nucleus
together with ER and organelles and also between lipid
Figure 5. IAPP immunoreactivity is present both intra- and extracellularly in hproIAPP and hIAPP expressing flies. The nls-GFP (green)
expression was driven by elav
C155,Gal4 and included to help to identify the cell nuclei in expressing cells. In control flies (A), IAPP-immunoreactivity is
absent as expected. In hproIAPP expressing flies, the IAPP-reactivity (red) is in (B) primarily present extracellularly, separated from the nls-GFP signal,
while in (C) the reactivity is intracellular and present adjacent to a nls-GFP labelled nucleus. In hIAPP expressing flies (D), IAPP-reactivity (red) is seen
both extra- and intracellularly. The study was performed on dissected whole mount fly brains. To enhance the intensity of the GFP-signal the brains
were also labelled with antibodies specific for GFP. The cell nuclei were labelled with TO-PRO-3 and visualized as blue. Flies were 30 days old.
doi:10.1371/journal.pone.0020221.g005
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be distinguished; a commonly present electron dense (Figures 9
A–D) and a less frequent lighter aggregate (Figures 9 B and D).
The dense granules had a size ranging from a few hundred nm
to many um in width. Not all aggregates appeared to be
membrane encircled and the large difference in size could
depend on granule fusion. When viewed longitudinally the
aggregates consisted of non-branching straight rope-like struc-
tures with a thickness of 15.8 nm. These rods were aligned in
parallel with a distance of 5 nm (Figure S6 A). The rod length
differed between granules, but they did not exceed 1 mm. In
cross-section, each rod had a pentagonal shape with a diameter
Figure 6. ProIAPP is not processed into IAPP. Sections from hproIAPP flies with the expression driven by elav
C155,Gal4 were used for
immunolabeling with two different antibodies. Antibody A142 is produced against the C-terminal flanking peptide of proIAPP, and antibody A169 is
produced against the N-terminal processing site. This antiserum will only bind to proIAPP, unprocessed at this region. The epitopes for A142 and
A169 are encircled in (A). Antiserum A142 labels cells inside the humoral-brain-barrier and in the head fat body (B). Antiserum A169 show the same
reactivity pattern (C, D). Antiserum-A169 reactivity within the head fat body supports that hproIAPP is not processed by amontillado.
doi:10.1371/journal.pone.0020221.g006
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protein granule consisted of groups of rods with different
orientations aligned perpendicular to each other (Figures S6 A
and C). We performed immunolabeling with monoclonal anti-
IAPP antibodies and polyclonal anti-IAPP antiserum, but both
failed to react with the aggregates. Instead, only occasional
reactivity was detected at the border of the aggregates (Figure
S6 C). Since fixation in 2% paraformaldehyde with 0.25%
glutaraldehyde and embedding in epon or in hydrophilic resin
could block epitopes recognized by the antibodies we performed
antigenic retrieval with sodium metaperiodate or H2O2.T h i s
p r e - t r e a t m e n tw a sw i t h o u ts u c c e s s ,b u ti ti ss t i l lm o s tl i k e l yt h a t
these aggregates arise from proIAPP or IAPP expression, this
because immunolabeling with the monoclonal anti IAPP
antibody on frozen sections and pFTAA labels the area
surrounding the cell nucleus (Figures 8 A and B), and in
TEM the highly ordered aggregates were the main structures
present at this location. Therefore, we believe that the compact
packaging of the molecules hinder recognition by antibodies. It
must be stressed that these aggregates were not present in
transgenic flies expressing the non–amyloid forming mIAPP or
in elav
C155,Gal4/+ (control) flies. The detected structure is
different from what has been described earlier to be found in
the fat body cells e.g by Locke et al., [50] in the larvae of the
butterfly Calpodes ethlius or by Tojo et al., [51] in the pupae of
the silkmoth, Hyalophora cecropia, and they are also different from
the aggregates detected in fat body cells in Drosophila melanogaster
after expression of double mutant TTR (TTRV14N/V16E) by
the GMR driver [52]. In these flies, expression of mutant TTR
was driven to the photoreceptors and aggregates were detected
in fat body cells of the brain and thorax. These TTR-derived
aggregates were determined to have a spherule shape with a
20 nm diameter. The spherules were arranged in a hexagonal
pattern and only occasionally short non-branched filaments
were detected among the spherules [52]. No similar analysis
seems to have been performed on the fat body of Ab expressing
flies. It is possible that proteins are assembled differently in
Drosophila and mammals, since no amyloid like fibrils could be
detected in electron microscopical analysis of sections from 16,
20 or 30 days old flies. Instead, we proposed that the IAPP and
p F T A As t a i n i n gs e e ni nF i g u r e s8Aa n dBa r es h o w i n gt h e
dense protein aggregate structures despite the absence of
immunolabeling in the EM specimens.
Changes of the nuclei morphological were seen in 40 days old
hproIAPP and hIAPP expressing flies (Figure S5 B). Here, in some
nuclei the normal pattern with heterochromatin and euchromatin
had disappeared and was replaced by an evenly dotted pattern.
The size of an individual dot exceeded the size of a single
nucleosome, but it points to a complete fragmentation of the DNA
and initiation of cell death. All studied nuclei in control (Figure S5
A) and mIAPP (Figure S5 C) transgenic flies exhibited unchanged
appearance. We did not detect any brain vacuolization in our
transgenic flies as it has been described to occur upon TTR
expression [29,30,41]. Neither of these changes appeared in our
flies where the hproIAPP expression was driven to the photore-
ceptors by the GMR driver.
Conclusion. HproIAPP expression driven by the
elav
C155,Gal4 driver causes a significant reduction of the longevity
in Drosophila melanogaster. Expression of the amyloidogenic
hIAPP and non-amyloidogenic mIAPP did not shorten the
longevity and, instead their lifespan was comparable to control
flies expressing Gal4 only. Immunolabeling for IAPP revealed
reactivity associated with a low number of neurons, but IAPP
reactivity was present both intracellularly and extracellularly in
such cells. The occurrence of immunoreactivity outside cells
indicates presence of protein aggregates. The expression of Gal4
driven by elavC155 driver varies over time, and only few neurons
express Gal4 by day 30. This reduction of expression can be one
reason for the low toxicity experienced in flies expressing hIAPP.
The strong IAPP labeling of the head fat body in hproIAPP and
hIAPP expressing flies is indicative for accumulation of peptide at
this site. Reactivity in the head fat body of hproIAPP expressing
flies with an antibody specific for the N-terminal processing site of
hproIAPP show that hproIAPP is not processed by amontillado,
the mammalian PC2 homologue. After staining brain sections for
amyloid with Congo red and pFTAA, two amyloid specific dyes,
amyloid was found mainly in the fat body region with minor
deposits in the neurons. The expressed proteins contain a signal
peptide and they were expected to be secreted from the neurons.
Their accumulation in the cells of the fat body could be explained
Figure 7. The presence of amyloid deposits is demonstrated after staining with Congo red (upper panel) or with the polyelectrolyte
pFTAA (lower panel). Frozen brain sections from control flies and from hproIAPP, hIAPP and mIAPP expressing flies were stained for amyloid. No
amyloid could be detected in control flies (A) or in flies expressing the non-amyloid forming mIAPP (D). Amyloid was visualized in hproIAPP (B) and
hIAPP (C) transgenic flies in regions corresponding to the expressing neurons, but also to the fat body. Positive staining is indicated by arrows. Congo
red staining was viewed at 546 nm with a helium-neon laser and pFTAA staining was viewed at 488 nm with an argon laser. Green and red signal in
control and mIAPP expressing flies depends on chitin in the exocytoskeleton. Flies were 30 days old.
doi:10.1371/journal.pone.0020221.g007
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fat body cells. The dense granular aggregates present in fat body
cells had a rod-like appearance with a pentagonal shape in cross-
section. This structure was different from those earlier described,
and we suggest that packing of proteins is different in Drosophila
and mammals. The absence of amyloid or protein aggregates in
mIAPP expressing flies strengthens the link between hproIAPP or
hIAPP expression and the pathological findings.
Figure 8. IAPP immunoreactivity co-localizes in part with pFTAA staining. In the fat body region of hproIAPP (A) and hIAPP (B) expressing
flies IAPP (red) reactivity is detected in the cytoplasm of the cells in the fat body. The pFTAA (green) staining co-localized with IAPP immunoreactivity
is indicated by arrows. IAPP (red) labelled regions not recognized by pFTAA are expected to be in non-fibrilar configuration. These regions are
indicated by arrow heads. In the neurons, IAPP (red) and pFTAA (green) co-localize extracellularly (C). This assumption is based on the size of the cell
nuclei.
doi:10.1371/journal.pone.0020221.g008
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Transgenic constructs and Drosophila strains
cDNA of human preproIAPP with the human IAPP signal
peptide was cloned into the pUAST vector at the EcoRI/XhoI
multiple cloning site to generate UAS-proIAPP transgenes. UAS-
hIAPP and UAS-mIAPP transgenes were generated by cloning the
respective cDNA into a modified pUAST vector with the signal
peptide of human proinsulin. This signal peptide was codon
optimized for Drosophila. Germ-line transformants were generated
in flies with the w
1118 background by standard technique [53]. The
sequence of the transgene was verified by DNA sequencing using
the forward primer 59- CCAGCAACCA AGTAAATCAA CTGC
-39 and the reverse primer 59- GGCATTCCAC CACTGCTCCC
ATT – 39. These primers bind to regions upstream respectively
downstream of the transgene.
The Gal4 driver lines w
1118; P(Gal4)repo/TM3,Sb, w
1118
(GawB)elav
C155, w
1118; P(Gal4-ninaE.GMR) 12, y
1w
67c23;
P(GawB)7B,a n dw
1118; P(GawB)D42 were obtained from
Bloomington Drosophila Stock Centre, Indiana University,
and the UAS-nlsGFP (nuclear leading sequence) line was
kindly provided by S. Thor, Linko ¨ping University. Expression
of the UAS-constructs was induced by crossing the UAS
transgenes with the respective Gal4 driver line [54]. Progeny
from crosses of the Gal4 lines with w
1118 flies were used as
controls (Gal4/+).
All crosses and experiments were performed on flies kept in an
incubator (KBWF 720, Binder) with 70% relative humidity, at a
12-hour light/12-dark cycle, at 26uC unless otherwise stated. The
flies were cultured on standard food (yeast, syrup, corn meal, and
agar). Transgenic flies were transferred to new vials every 2–3 days.
Quantitative polymerase chain reaction
RNA was extracted from ten, 5 days old female flies from each
transgenic group by homogenization in QIAzol lysis reagent
(Qiagen, Hilden, Germany) and purification by RNeasy MinElute
cleanup columns (Qiagen) according to protocols supplied by the
manufacturer. RNA concentrations were determined and 1 mg
was used for first strand cDNA synthesis with oligo-dt primer
(Fermentas GmbH, St. Leon-Rot, Germany) and the incubation
condition 42uC for 1 hour. The reaction was terminated by
5 minutes incubation at 70uC. Real-time PCR reactions were
performed and hproIAPP and hIAPP were amplified with forward
primer 59-GCAGCGCCTGGCAAATT and reverse primer 59-
GGTAGATGAGAGAATGGCACCAA, mIAPP was amplified
with forward primer 59-CGCCGGCAAGTGCAA and reverse
primer 59-GCTGGAACGAACCAAAAAGTTT and RP49 (en-
dogenous control) was amplified with forward primer 59-
TGTCCTTCCAGCTTCAAGATGACCATC and reverse 59-
CTTGGGCTTGCGCCATTTGTG. The QT-PCR reaction
contained 20 ng cDNA, 300 mmol primer and 15 ml Cyber green
(Roche diagnostics GmbH, Mannheim, Germany) and was
Figure 9. Protein granules accumulate in 30 days old flies with hproIAPP expression driven by elav
C155,Gal4. In (A, B) an accumulation of
electron dense aggregates can be seen. At higher resolutions (C, D) it is shown that these darker aggregated contain a defined pattern. The cell
nucleus is pseudo-stained blue (A, B).
doi:10.1371/journal.pone.0020221.g009
Islet Amyloid Polypeptide in Drosophila
PLoS ONE | www.plosone.org 12 June 2011 | Volume 6 | Issue 6 | e20221performed on a Fast Real-Time PCR system (Applied biosystems,
Sweden) and the SDS 2.3 software. Relative expression of mRNAs
was calculated with the 2
2DDCT method, where DCt=Ct(target)
2Ct(endogenous control).
Life span analysis
Newly hatched flies were collected and females were separated
from male flies after 24 hours and divided in groups of 20 flies per
vial. Mated female flies, 100–150 from each genotype were aged on
standard food and the numbers of surviving flies were scored daily.
The flies were transferred to new vials every other day. Statistical
analysis was performed using GraphPad Prism 4 (GraphPad
Software Inc., La Jolla, CA). Kaplan-Meier survival curves were
compared separately for each experimental pair by log rank tests.
Immunohistochemistry
Aged transgenic flies were carefully decapitated, embedded in
Tissue-TekH O.C.T.
TM Compound (Histolab, Gothenburg, Swe-
den) and stored at 280uC, until used. The embedded heads were
brought to 217uC, cut into 10-mm sections and were placed on
SuperFrostHPlus slides (Menzel-Gla ¨ser, Braunschweig, Germany).
The sections were fixed for 10 min in 4% (w/v) paraformaldehyde
(PFA) in 0.1 M phosphate buffer with 0.15 M NaCl, pH 7.4
(PBS), and treated in methanol-H2O2 (20% w/v) to eliminate
autofluorescence, as previously described [30]. Unspecific binding
was blocked by incubation in PBS with 0.2% Triton X-100 (PBT)
and 10% fetal calf serum (FCS) for 1 h, at room temperature.
Primary antibodies, monoclonal mouse anti-IAPP (SM1341, Acris
Antibodies, Herford, Germany) diluted 1:100, rat monoclonal
anti-elav (7E8A10, Developmental Studies Hybridoma Bank,
University of Iowa) diluted 1:20, polyclonal rabbit antibody
against the N-terminal processing site of proIAPP (A169, [11])
diluted 1:25, polyclonal rabbit antibody against the C-terminal
flanking peptide (A142, [44]) diluted 1:200, and polyclonal rabbit
antibody against human IAPP (A133, [11]) diluted 1:250 in
blocking solution were incubated overnight, at 4uC. The following
day, sections were rinsed three times 10 min in PBT and the
reactivity was detected by Alexa FluorH 488 (donkey anti-rat,
A21208, 1:1000, Molecular Probes) and Alexa FluorH 546 (goat
anti-rabbit, A11035, 1:500, Molecular Probes), respectively.
Finally, the sections were rinsed three times 10 min in PBT and
mounted with PBS/glycerol (1:1) containing 1 mM To-Pro-3
iodide (T3605, Molecular Probes).
Whole brains of adult Drosophila melanogaster were carefully
dissected in PBS and fixed in 4% PFA - PBS for 20 min on ice.
After fixation, brains were rinsed 365 min in PBT and unspecific
binding was blocked by incubation in PBT containing 5% FCS,
1 hour at room temperature. The brains were then incubated with
primary antibody diluted in blocking solution for 36 hour, at 4uC.
Primary antibodies were polyclonal rabbit anti-GFP (TP401,
Torrey Pines Biolab) diluted 1:2000, monoclonal mouse anti-IAPP
(SM1341, Acris) diluted 1:50, and monoclonal mouse anti-
bruchpilot (nc82, DSHB) diluted 1:20. After incubation with
primary antibodies, the brains were rinsed three times 40 minutes.
Secondary antibodies (Alexa FluorH 488 goat anti-rabbit, A11008,
1:500; Alexa FluorH 546 goat anti-mouse, A11030, 1:500;
Molecular Probes) were diluted in blocking solution and brains
were incubated for 24 hours at 4uC followed by 3640 minutes
rinses in PBT at room temperature. Finally, brains were mounted
with PBS/glycerol (1:1).
Congo red staining
Cryosections (10 mm) were dried onto plus slides and fixed in
95% ethanol for 18 hours, at 220uC, hydrated in 70% ethanol
and PBS, at room temperature. Sections were stained for amyloid
by 20 minutes incubation in solution A (NaCl-saturated 80%
ethanol with 0.01% NaOH) followed by 20 minutes incubation in
solution B (solution A saturated with Congo red) (Sigma,
Stockholm, Sweden) [55]. Slides were rinsed in absolute alcohol,
xylene and mounted with Mountex (Histolab).
Pentameric formic thiophene acetic acid staining
(pFTAA)
Cryosections (10 mm) were dried onto plus slides and fixed in
95% ethanol for 18 hours, at 220uC, hydrated in 70% ethanol
and PBS, at room temperature. Sections were stained for amyloid
by incubation with 7.5 mM pFTAA diluted in PBS for 20 minutes
[45,46,47] followed by a short rinses with PBS and water. Slides
were mounted with PBS/glycerol (1:1).
Confocal analysis
Sections and whole brain specimens were examined with a Nikon
eclipse E600 microscope connected to a Nikon C1 confocal unit
with argon 488 nm and HeNe 543 nm, and HeNe 633 nm lasers
(Nikon, Kawaski, Japan). Sections stained for amyloid with Congo
red were studied with confocal microscopy with a HeNe 543 nm
laser and sections stained for amyloid with pFTAA were studied
with confocal microscopy using an argon 488 nm laser. Pictures
were taken with an EZ-C1 digital camera. Images were processed
and analyzed with Volocity 4 imaging software (Improvision Inc.,
Waltham, USA) and Photoshop Elements 4.0 (Adobe).
Transmission Electron Microscopy (TEM)
Flies were carefully decapitated and the heads were fixed in 2%
PFA and 0.25% glutaraldehyde in PBS for 24 hours followed by
post-fixation in 2% OsO4 and embedded in EPON (Ladd
Research Industries, Burlington, USA). Ultrathin sections were
placed on nickel grids and contrasted with 2% uranyl acetate in
50% ethanol and Reynolds lead solution. The material was
studied at 100 kV in a Jeol 1230 electron microscope (Jeol,
Akishima, Japan). Electron micrographs were taken with a Gatan
multiscan camera model 791 using Gatan digital software version
3.6.4 (Gatan, Pleasanton, USA).
Supporting Information
Figure S1 The survival of four different hproIAPP
expressing lines is compared with the survival of control
flies, elav
C155,Gal4/+. The single transgenic lines hproI-
APP#14.2 (green) and hproIAPP#18.5 (purple) showed signifi-
cant reduction in survival, p.,0.0001 and 0.0175, respectively,
while the survival of flies from the hproIAPP#20.4 (blue) was not
significantly reduced (p 0.0577). The double-transgenic (orange)
line was established by combining hproIAPP#14.2 with
hproIAPP#20.4. Flies from this strain show shorter lifespan than
control flies (p,0.0001).
(TIF)
Figure S2 A brain from Drosophila melanogaster where
nlsGFP (green) expression is driven by elav
C155,Gal4. This
is done to visualize the areas for protein expression driven by this
driver. The neuropil is labelled with an antibody reactive against
the neuropil specific protein bruchpilot (red). Survival of hproIAPP
flies was also studied at 18uC (B) and 29uC (C). The expression of
hproIAPP shortened the survival at all temperatures, but an
increased temperature resulted in shorter lifespan. This is
independent of the transgene and it is in line with the knowledge
that flies live shorter at higher temperature. The survival of
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shown in black.
(TIF)
Figure S3 In an initial study we investigated the effects
of hproIAPP expression driven by other drivers. In this
study, motor neurons, mushroom body, glia cells (repo-Gal4), and
photoreceptor cells (GMR-Gal4) were included. In the left panel of
(A, B, C, D), the respective driver was used for expression of
nlsGFP to visualize cell regions involved in expression. In the right
panel the survival curves are shown for each respective driver. It
can be noted that expression of hproIAPP did not cause any
reduction of the survival of the flies. With repo-Gal4 and GMR-
Gal4 it enhanced survival. The expression of hproIAPP is shown
in green and control flies in black. In (E), the median fly survival of
the different strains is shown in comparison to flies expressing
hproIAPP with the elav
C155,Gal4 driver.
(TIF)
Figure S4 The GFP expression driven to neurons by the
elav
C155,Gal4 driver was analysed in 1, 5 15 and 30 days
old flies. The pattern of nlsGFP expression changes over time
and only few cells express GFP at day 1. There is a dramatic
increase in GFP expression by day 5 and already at day 15 is the
GFP positive area decreased. In brains from 30 day old flies is the
GFP expression similar to that detected in 1 day old flies. The
nlsGFP expression pattern was studied in dissected whole brains
after immunolabeling with a primary antibody against GFP that
was visualised by an Alexa-488 labelled secondary antibody.
(TIF)
Figure S5 Electron micrographs of a 40 day old control
fly and transgenic hIAPP and mIAPP flies with expres-
sion driven by elav
C155,Gal4. Shown areas are from the fat
body of the head. In addition to protein accumulation in the
cytoplasm (shown in Figure 9) a morphological alteration of some
nuclei occurs in flies expressing hIAPP (B). In these nuclei, the
euchromatin has lost its homogeneity and has instead adopted a
dotted pattern. This morphological change of the cell nucleus is
also present in flies expressing hproIAPP (not shown), but it is
absent in control flies (A) and in flies expressing the non-
amyloidogenic mIAPP (C).
(TIF)
Figure S6 Ultrathin sections from rod-like aggregates
present in fat body cells of hproIAPP expressing flies.
Rods with a thickness of 15.8 nm are aligned in parallel and
separated by an empty space of 5.2 nm. The individual aggregates
consist of both longitudinal and cross sectioned rods and these are
arranged perpendicular to each other (A). Cross-sectioned
filaments have a pentagonal shape (B). In (C) is IAPP
immunoreactivity indicated by arrow heads. The reactivity
appears in close association to ends of the rods.
(TIF)
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